Comparison of two drugs for awake airway intubation in anaesthesia

Comparison of fentanyl and nalbuphine on intubating conditions and haemodynamic responses during awake fiberoptic intubation

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/011696

Enrollment

Registered

2018-02-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients posted for Surgery under General Anaesthesia

Interventions

Intervention1: Intravenous Nalbuphine with intravenous Fentanyl: 0.2mg/kg Intravenous Nalbuphine with 2microgm/kg Intravenous Fentanyl Control Intervention1: Intravenous Fentanyl with intravenous Nalb

Eligibility

Inclusion criteria

Inclusion criteria: Patients belonging to American society of Anaesthesiology grade I and grade II Patients belonging to MPG-I and MPG-II and Weight 40to 80 kg

Exclusion criteria

Exclusion criteria: Patient refusal Patient with known allergy to trial drugs ASA-III and ASA-IV patients MPG-III and MPG-IV patients Emergency and obstetric surgeries Patients with respiratory disease Patient on beta blockers

Design outcomes

Primary

Measure	Time frame
Cough score Tolerance to intubation was evaluated by post intubation score Level of sedation was evaluated by Ramsay sedation scoreTimepoint: 0,5,10,15,20	—

Secondary

Measure	Time frame
Heart rate Systolic Blood Pressure and Diastolic Blood Pressure Mean Arterial Pressure Spo2Timepoint: 2,5,10,15 minute after intubation	—

Countries

India

Contacts

Public ContactSujata Chaudhary

University College Of Medical Sciences

sujatac462@gmail.com9868399705

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026